logo
Win Or Learn: The Entrepreneur's Mindset

Win Or Learn: The Entrepreneur's Mindset

Forbes27-05-2025
Daniel is an entrepreneur, founder & CEO of MyOutDesk devoted to providing growing companies with proven, reliable virtual assistants.
The common framing around failure in entrepreneurship—of things being win or lose—doesn't work for me. You're either winning or you're learning, and learning is iterative and 'the entrepreneur's mindset.'
I've been establishing, growing and selling businesses for almost 20 years, and that's the mindset I decide to approach every entrepreneurial endeavor with. I know 18% of small businesses fail within their first year (and 50% within the first five), but I also know there are a lot of people like me out there who also decide every day to pursue a passion or idea that's as likely to fail as it is to succeed.
That decision is the first of a million-plus decisions entrepreneurs have to make. And there are just as many different routes that could get them where they want to go. As someone who's faced the inevitable decision paralysis countless times and worked with thousands of entrepreneurs who've experienced the same, I've learned a few tricks for turning decision paralysis into progress—because action, even if in the wrong direction, is better than stagnancy.
Is taking the initial leap the hardest part … or everything that comes after it? Well, that's for each founder to decide. What isn't up for debate is that the decisions made during the ideation and planning phases of the entrepreneur have the power to significantly impact future business success.
Product-market fit is paramount. Find a clear path to customer demand, and offer customers a value proposition that no other company can. While your business idea must be unique, the elevator pitch for it can be formulaic: I provide this (product/service) for people (describe the person/customer/business) that want (outcome). In its simplest form, business is humans helping other humans; if you're good, then the business will grow.
To be good, you must commit to a pursuit of mastery. A dedication to your business's growth and development is a dedication to your own personal growth and development as well. Ongoing education and improvement in marketing, operations and delivery are critical, but sales mastery is nonnegotiable as founders are constantly selling their vision to customers, investors and employees.
Consider whether a blended workforce is the right choice for you. It can be a good idea to hire internal staff for the most technical and high-value tasks, and hire outsourced staff for the process-based tasks. (Disclosure: My company helps with outsourcing, as do others.) But for many entrepreneurs, the first 'hire' should be a technology system like a CRM or ERP platform that supports those team members and you in every business decision from customer acquisition to product or service distribution. This kind of blended model that employs physical, virtual and digital team members takes advantage of the strength of AI in its current era and gives humans the ability to leverage that technology to help better the business.
Some of the most common entrepreneurial decisions are the most difficult to make because there's no right or wrong answer or one answer that fits every entrepreneur. The good news is, in my experience, it's less about what you decide and more about how.
Separate CEO from self. It's your business, but the business is not you. It should be treated as its own entity, and decision-making should be based on what's best for the company, not the individual(s) running it, because those are not always one and the same. Founder compensation is a good example. While taking a salary is typically preferred from a personal perspective, it may not be best for a new business that still has entry-level revenue and weak financial stability. As the business grows and scales, so can the market value (and salary) of the CEO.
Focus on the long term. I've learned that effective leaders prioritize the long-term health and mission of the business above personal gain or convenience. They lead 'from the front,' never asking employees to do something they wouldn't be willing to do themselves. This approach can foster trust, build credibility and effectively motivate teams to stay the course in the short term for better results in the long run—results that everyone on the team will professionally and personally benefit from.
Do the due diligence to turn curiosity into context. Ask questions. Understand the 'what' and the 'why' of every situation, be it managing employee performance or evaluating pitches promising grandiose visions. As a founder, you'll inevitably possess a broader context than individual contributors and must tailor your communications and operations decisions to reflect that big-picture view.
Be okay with saying no—strategically. It's a necessary skill for leaders to protect their business, their time, the team doing the work and the customers they serve. Establishing guardrails early on and sticking to a disciplined evaluation process when determining things like whether or not to hire friends and family or take on investors can prevent biased decision-making based on familiarity or immediate appeal instead of true business and customer needs.
Often, situations are less about the decision and more about how you approach making it—less about a founder's checklist and more about a founder's willingness to take risks.
While market opportunity and product-market fit are paramount, successful entrepreneurship often stems from an innate drive and passion for pursuing a vision. It takes courage, commitment and an inner self-assuredness to turn a gut feeling into a foundation for a profitable venture, not another failure statistic.
Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

1 Green Flag for Fluor Stock Right Now
1 Green Flag for Fluor Stock Right Now

Yahoo

time19 minutes ago

  • Yahoo

1 Green Flag for Fluor Stock Right Now

Key Points Fluor's second-quarter report arrived at the beginning of this month with big sales and earnings misses. While macroeconomic uncertainty weighs on the company's momentum, the business still has a big sales backlog. Fluor could continue to see volatile trading, but the company's backlog and exposure to AI infrastructure power trends suggest the stock could have big upside. 10 stocks we like better than Fluor › Fluor (NYSE: FLR) published its second-quarter results at the beginning of August, and performance for the period came in significantly below the average Wall Street analyst estimate. The engineering and construction specialist posted non-GAAP (adjusted) earnings per share of $0.43 on revenue of $3.98 billion in the period, falling short of the consensus target's call for per-share earnings of $0.56 on sales of roughly $4.7 billion. Revenue unexpectedly fell 6% year over year in the period. Fluor stock saw a big sell-off in conjunction with the weaker-than-expected Q2 print, and its share price is down roughly 23.5% across August's trading as of this writing. While Fluor has seen a huge valuation pullback this month, there's also a positive sign for the company. There's one big green flag for Fluor stock at current pricing levels Fluor's Q2 report arrived with some disappointing results, but some dynamics suggest that the stock could rebound well above current levels following the big pullback. Fluor notched $1.8 billion in new bookings in the second quarter, with 72% of those bookings being reimbursable. Meanwhile, the company's total bookings backlog stood at $28.2 billion, with 80% of that figure being reimbursable. Even though total bookings saw a drawdown from the $28.7 billion level at the end of the previous quarter, there are still clear indications that large, previously contracted deals are being converted into sales. Macroeconomic uncertainty has presented a significant performance headwind for Fluor, but the business's sizable backlog suggests that the business is attractively valued with a market capitalization of roughly $7 billion. Fluor's majority ownership position in NuScale Power gives it significant exposure to the rise of nuclear power being used to power artificial intelligence (AI) data centers, and the relatively high degree of visibility on the company's forward sales outlook suggests that the stock could have a favorable risk-reward dynamic at current levels. Should you invest $1,000 in Fluor right now? Before you buy stock in Fluor, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Fluor wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,544!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,113,059!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool recommends NuScale Power. The Motley Fool has a disclosure policy. 1 Green Flag for Fluor Stock Right Now was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Congressman Morgan Luttrell Tours Hertha Metals' Texas Plant Driving U.S. Steel and Iron Independence
Congressman Morgan Luttrell Tours Hertha Metals' Texas Plant Driving U.S. Steel and Iron Independence

Yahoo

time19 minutes ago

  • Yahoo

Congressman Morgan Luttrell Tours Hertha Metals' Texas Plant Driving U.S. Steel and Iron Independence

CONROE, Texas, August 14, 2025--(BUSINESS WIRE)--On August 11th, CEO Laureen Meroueh and Hertha Metals – a domestic steel and high-purity iron producing company based out of Conroe – hosted Congressman Morgan Luttrell for a tour of Hertha Metals' plant. During the tour, Congressman Luttrell saw Hertha's one-step furnace in action: turning low-grade domestic ore and millscale into high-purity iron for rare earth magnets used in defense, energy, and electronics. The visit also spotlighted Hertha's upcoming 9,000-tonne-per-year plant, set to bring 550 jobs and strengthen America's industrial security. "It was an honor to welcome Congressman Morgan Luttrell to our Conroe plant," said Laureen Meroueh, CEO of Hertha Metals. "By producing high-purity iron domestically, we're reducing America's reliance on foreign supply chains for materials critical to defense, energy, and advanced manufacturing – all while creating more than 550 jobs and making Conroe a cornerstone of America's industrial future." "The United States is the world's largest steel importer yet has no domestic source of high-purity iron. China exports over 90 percent of the high-purity iron in rare earth magnets – a reliance that poses a direct threat to America's industrial and national security," said Congressman Morgan Luttrell (R-TX). "Hertha Metals is changing that and meeting the moment by creating a 9,000 tonne per year plant in Conroe with enough capacity to meet the country's demand in the rare earth magnet market. I'm proud that this new high purity iron production plant will generate over 500 jobs in my district." More Background: Hertha Metals is revitalizing American-made high-purity iron and steel manufacturing through innovation. By leveraging abundant U.S. natural gas and domestic iron ore, Hertha developed a next-generation steelmaking process that delivers high-purity iron, as well as high performance steel, using our country's abundant resources. By 2030, Hertha Metals will scale steel production to 500,000 tonnes annually, a commercial steel micro mill. To learn more, visit View source version on Contacts media@

Nootropics Market Size Projected to Attain USD 19.53 Billion by 2034
Nootropics Market Size Projected to Attain USD 19.53 Billion by 2034

Yahoo

time19 minutes ago

  • Yahoo

Nootropics Market Size Projected to Attain USD 19.53 Billion by 2034

The global nootropics market is valued at USD 5.71 billion in 2025 and is projected to reach approximately USD 19.53 billion by 2034, expanding at a CAGR of 14.64% during the forecast period. Ottawa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global nootropics market size was valued at USD 4.98 billion in 2024 and is projected to reach approximately USD 19.53 billion by 2034, growing at a CAGR of 14.64%. The industry's growth in recent years has been driven by rising awareness of mental health issues. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America dominated the market with the largest market share in 2024. Asia Pacific is anticipated to grow at the fastest rate in the nootropics market over the forecast period. By form, the capsules/tablets segment led the market in 2024. By form, the drinks segment is predicted to witness the fastest growth in the market over the forecast period. By distribution channel, the offline segment dominated the market in 2024. By distribution channel, the online segment is anticipated to grow at the fastest rate in the nootropics market during the forecast period. Market Overview & Potential The increased interest in brain health and mental performance is spearheading the industry growth in recent years. As the younger individuals are contributing significantly to the majorly in this industry by adopting these supplements for the increasing focus, mood, and creativity in the current period. Moreover, the products include ingredients like caffeine, ginseng. L-thenine is more popular in the industry nowadays. What are the Key Growth Drivers Involved in The Expansion of The Market? The rising need for cognitive enhancement among the working professional community is spearheading the industry growth in the current period. Moreover, the nootropic manufacturer are actively looking to create partnerships with the big corporate firms to lead their business in the current period. Furthermore, by providing several advantages such as improved memory, mental energy, and concentration to consumers, the nootropic supplements have gained immense industry attention in recent years. In December 2024, Cristiano Ronaldo invested $15 million in personalised nutrition company Bioniq, increasing the value of the company to $82 million. What Are the Emerging Trends Associated with the Market? The sudden shift towards plant-based and herbal nootropics has driven the industry growth in recent years. The rising popularity of functional beverages, such as drinks with brain-boosting ingredients, has contributed to the industry's growth in the past few years. You can place an order or ask any questions, please feel free to contact us at sales@ Regional Analysis How Did North America Dominate the Market in 2024? In 2024, North America led the nootropics market owing to the increased need for cognitive enhancement in the current period. Moreover, the market growth is mainly associated with factors such as the high awareness and acceptance of the mental wellness supplement in recent years in the region. Furthermore, the greater regulatory push has contributed immensely in the region, as per the recent regional survey. What Made the Asia Pacific Significantly Grow in the Market in 2024? In the nootropics market, the Asia Pacific is predicted to grow at the fastest CAGR during 2025-2034, akin to the rising mental awareness and the development of e-commerce platforms. Moreover, the regional countries such as India, China, and Japan are seen under the sophisticated growth in the wellness market in recent years. Furthermore, the younger population in the region is expected to drive the future growth of the industry, as they are seen as heavy adopters of nootropics for professional and academic performance. Segmental Insights By Form Analysis How did the Capsules and Tablets Segment Dominate the Market in 2024? The capsules and tablets segment held a major share of the nootropic market. Mainly, the segment is driven by its unique properties, such as the convenience, wide availability, and accurate dosage in the current period. Moreover, the individuals are actively seen preferring the tablet forms of the dosage due to traditional habits, which is driving the growth of the market in the present period, as per industry observation. How will the Drink Segment Expand Rapidly During 2025-2034? The drink segment is estimated to register rapid expansion during the forecast period due to its excellent characteristics like faster absorption, convenience, and on-the-go consumption facilities. Several nootropic ingredients, such as L-theanine, caffeine, and others, are actively seen in gaining immense attention from the younger generation, which is expected to lead the segment growth in the upcoming years. Moreover, factors such as the fast-paced and modern lifestyle are contributing to the segment's potential in the current phase. Become a valued research partner with us - By Distribution Channel, The offline segment dominated the market with the largest share in 2024. The offline channels, such as health stores, pharmacies, and supermarkets, remain key sales points for nootropics. These locations allow customers to get expert advice, see physical products, and make instant purchases. Many customers still prefer in-person purchases due to trust and habit. Retailers also offer bundled promotions and loyalty benefits, which boost foot traffic. The online segment is expected to grow at a significant rate due to increasing digital adoption, easy product comparison, and greater availability of global brands. E-commerce allows consumers to browse a wide range of nootropic supplements, read reviews, and access educational content before purchasing. Subscription models and influencer marketing have also accelerated growth. The convenience of doorstep delivery and targeted advertising helps brands connect with consumers more effectively. Recent Developments The first nootropics food lab in Canada was established in January 2025 by Raymond Thomas, a biology professor at Western University. The lab creates brain-boosting meals by fusing Western science with Indigenous dietary expertise. To promote brain health through functional meals, Thomas and his colleagues will develop novel dishes in collaboration with an in-house chef and utilize biochemistry and metabolomics to assess their cognitive effects. In February 2025, the Scientific Advisory Board and Research Snapshot sections were launched by Nootropics Depot to increase openness and confidence in the supplement sector. The new advisory board will supervise product formulations and study evaluations to guarantee the highest levels of safety and efficacy. It will include specialists in integrative medicine, fitness, plant biology, and ethnobotany. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes schedule a call today: Nootropics Market Key Players Nootropics Depot Kimera Koffee Alternascript Cephalon LLC Teva Pharmaceuticals Onnit Powder City Mental Mojo Llc Mind Lab Pro Purelife Bioscience Company Ltd TruBrain Noocube Browse More Insights of Towards Healthcare: The global liquid biopsy IVD market was valued at US$ 2.21 billion in 2024 and is expected to reach US$ 2.54 billion in 2025. Projections indicate the market will grow to approximately US$ 8.72 billion by 2034, registering a CAGR of 14.79% during the forecast period. The liquid biopsy tube market stood at US$ 1.34 billion in 2024, rising to US$ 1.54 billion in 2025, and is anticipated to reach US$ 5.32 billion by 2034, expanding at a CAGR of 14.85% from 2025 to 2034. The specialty medical chairs market is valued at USD 5.12 billion in 2025 and is projected to climb to around USD 9.77 billion by 2034, growing at a CAGR of 7.43% over the forecast period. The biosensors market was valued at USD 30.04 billion in 2024, increasing to USD 32.64 billion in 2025, with expectations to reach USD 68.72 billion by 2034 at a CAGR of 8.64% from 2025 to 2034. The stem cell therapy market was worth USD 490 million in 2024, grew to USD 613.7 million in 2025, and is projected to reach around USD 4,777.40 million by 2034, expanding at a notable CAGR of 25.26% between 2025 and 2034. The home healthcare market is forecast to expand from USD 226.92 billion in 2025 to USD 476.80 billion by 2034, recording a CAGR of 8.6% over the analysis period. The regenerative medicine market is set to surge from USD 24.39 billion in 2025 to USD 139.70 billion by 2034, achieving a robust CAGR of 21.4%. The mice model market was valued at US$ 1.57 billion in 2024, increased to US$ 1.73 billion in 2025, and is expected to reach approximately US$ 4.1 billion by 2034, registering a CAGR of 10.04% during the forecast timeframe. The cancer biopsy market stood at US$ 30.81 billion in 2024, grew to US$ 36.61 billion in 2025, and is projected to soar to about US$ 163.29 billion by 2034, expanding at an impressive CAGR of 18.84% between 2025 and 2034. Meanwhile, the in vivo CAR-T platform market is gaining momentum worldwide, with expectations of generating hundreds of millions in revenue during the 2025–2034 period. Segments Covered in The Report By Form Capsules/Tablets Powder Drinks Others By Distribution Channel Offline Online By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Immediate Delivery Available | Buy This Premium Research @ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region - +44 778 256 0738 North America Region - +1 8044 4193 44 Web: Find us on social platforms: LinkedIn | Twitter | InstagramErreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store